195. Menopause Hormone Therapy: What the WHI Got Wrong and What the FDA Finally Fixed | Lauren Spivack, MD


Dr. Lauren Spivack is a board-certified OB-GYN, Menopause Society Certified Practitioner, and fellowship-trained minimally invasive gynecologic surgeon. She treats patients in South Jersey and through the evidence-based telehealth platform Alloy (https://www.myalloy.com/). In this episode, we break down the Women's Health Initiative, the FDA's 2025 removal of the black box warning from estrogen products, the newly named musculoskeletal syndrome of menopause, testosterone in women, and why the formulation you choose matters more than most providers realize.
What We Discuss:
00:00 HRT Timing Window
00:25 Meet the Hosts
01:19 Dr Spivack Background
02:47 Pelvic Pain to Menopause
03:34 Menopause Care Gaps
09:19 Defining Menopause Stages
11:01 WHI Study Breakdown
19:37 Why Age Matters
21:59 Recognizing Symptoms
25:32 Musculoskeletal Links
27:57 Team Based Referrals
31:33 FDA Label Update
34:23 Bioidentical vs Compounded
36:51 Vaginal Estrogen GSM
39:43 Systemic Options and Risks
45:54 Dosing and Expectations
46:57 HRT Starting Doses
48:08 Progesterone Dosing Basics
48:53 Perimenopause and HRT
51:16 Breast Cancer Risk Talk
55:12 When HRT Is Not Right
58:39 Lifestyle and Sleep Focus
01:01:46 Progesterone Only Option
01:03:04 Testosterone for Women
01:07:13 Labs and Monitoring
01:11:56 HRT Hype and Telehealth
01:20:51 Overtreatment and Pellets
01:23:33 Fixing Menopause Care
01:26:25 Putting Health Back
01:28:43 Wrap Up and Disclaimer
Studies & Literature Mentioned:
WHI Original Trial: Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women (https://pubmed.ncbi.nlm.nih.gov/12117397/) (Rossouw et al., JAMA 2002)
WHI 30-Year Review: The Women's Health Initiative Randomized Trials and Clinical Practice (https://pubmed.ncbi.nlm.nih.gov/38691368/) (Manson et al., JAMA 2024)
Musculoskeletal Syndrome of Menopause: The Musculoskeletal Syndrome of Menopause (https://pubmed.ncbi.nlm.nih.gov/39077777/) (Wright et al., Climacteric 2024)
FDA Announcement: HHS Removes Misleading FDA Warnings on Hormone Replacement Therapy (https://www.fda.gov/news-events/press-announcements/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy) (November 10, 2025)
HHS Fact Sheet: FDA Initiates Removal of Black Box Warnings from MHT Products (https://www.hhs.gov/press-room/fact-sheet-fda-initiates-removal-of-black-box-warnings-from-menopausal-hormone-replacement-therapy-products.html)
Veozah (Fezolinetant): FDA Safety Communication on Liver Injury Risk (https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due)
Concepts & People:
Dr. Vonda Wright (https://www.womensportsforummd.com/) — Orthopedic surgeon, lead author on the musculoskeletal syndrome of menopause paper
Dr. Mary Claire Haver (https://thepauselife.com/) — OB-GYN, author of The New Menopause (NYT Bestseller)
Dr. Lisa Mosconi (https://www.lisamosconi.com/) — Neuroscientist, Director of the Women's Brain Initiative at Weill Cornell, researching estrogen and Alzheimer's risk
The Menopause Society (https://menopause.org/) — Professional organization and certified menopause provider directory
Mark Cuban Cost Plus Drugs (https://www.costplusdrugs.com/) — Affordable medication option for uninsured patients
Connect with Dr. Spivack:
Alloy Profile: Dr. Lauren Spivack (https://www.myalloy.com/expert/lauren-spivack)
Virtua/Rowan Medicine: Provider Profile (https://doctors.virtua.org/provider/lauren-spivack/2136705)
LinkedIn: Lauren Spivack, MD (https://www.linkedin.com/in/lauren-spivack-937b8210/)
Connect with Medicine Redefined:
Website: medicineredefined.com
Instagram: @medredefined (https://www.instagram.com/medredefined/)
Twitter/X: @medredefined (https://x.com/medredefined)
Newsletter: The Progress Note
Work with Dr. Raja:
Refining Health & Performance: refininghealthrx.com
Dr. Raja's musculoskeletal and longevity practice (Telemedicine available in NJ, NY, PA, FL).












